Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol  by Radovan, Diana et al.
FEBS Letters 583 (2009) 1439–1445journal homepage: www.FEBSLetters .orgFluorescence microscopy studies on islet amyloid polypeptide ﬁbrillation at
heterogeneous and cellular membrane interfaces and its inhibition by resveratrol
Diana Radovan a, Norbert Opitz b, Roland Winter a,*
a Physical Chemistry I – Biophysical Chemistry, Department of Chemistry, Dortmund University of Technology, Otto-Hahn Str. 6, 44227 Dortmund, Germany
bMax-Planck Institute for Molecular Physiology, Otto-Hahn Str. 11, 44227 Dortmund, Germanya r t i c l e i n f o
Article history:
Received 3 February 2009
Revised 9 March 2009
Accepted 24 March 2009
Available online 2 April 2009
Edited by Jesus Avila
Keywords:
Amylin
Islet amyloid polypeptide
Type II diabetes mellitus
Amyloid
Giant unilamellar lipid vesicle
Model raft mixture
Fluorescence microscopy
Cytotoxicity0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.03.059
* Corresponding author.
E-mail address: roland.winter@tu-dortmund.de (Ra b s t r a c t
Type II diabetes mellitus (T2DM) is a disease characterized by progressive deposition of amyloid in
the extracellular matrix of b-cells. We investigated the interaction of the islet amyloid polypeptide
(IAPP) with lipid model raft mixtures and INS-1E cells using ﬂuorescence microscopy techniques.
Following preferential partitioning of IAPP into the ﬂuid lipid phase, the membrane suffers irrevers-
ible damage and predominantly circularly-shaped lipid-containing IAPP amyloid is formed. Interac-
tion studies with the pancreatic b-cell line INS-1E revealed that growing IAPP ﬁbrils also incorporate
substantial amounts of cellular membranes in vivo. Additionally, the inhibitory effect of the red
wine compound resveratrol on IAPP ﬁbril formation has been studied, alluding to its potential
use in developing therapeutic strategies against T2DM.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In recent years, a large number of proteins has been found to
be associated with so-called ‘‘conformational diseases”, the hall-
mark of such pathological conditions being the presence of ﬁbril-
lar amyloid deposits. Despite the general lack of similarity in the
primary structures of such proteins, ﬁbril formation and the asso-
ciated toxicity on the producing cells is a common characteristic
[1]. Also lipid membranes seem to play a key role in the forma-
tion of amyloid plaques, accelerating ﬁbril formation in vitro, as
shown by several studies, now [2–5]. The islet amyloid polypep-
tide (IAPP) is the main cytotoxic component of amyloidogenic
deposits found in 95% of patients suffering from type II diabetes
mellitus (T2DM) [6]. IAPP is a 37 a.a. residues peptide with a
disulﬁde bridge and an amidated C-terminus. Under normal con-
ditions, it acts as a hormone, i.e., as insulin antagonist, being co-
secreted along with insulin by pancreatic b-cells in the form of
proIAPP, which is then further processed to yield the mature IAPP
[7].
The interaction of IAPP with negatively charged membranes has
been extensively studied, and a mechanism of interaction has beenchemical Societies. Published by E
. Winter).proposed [4,8–11]. Here we would like to extend such studies to
model raft membrane systems, such as DOPC:DPPC:cholesterol
1:2:1, since heterogeneous membranes of this type are probably
playing an important role in many biological processes, such as
modulating a broad range of signaling cascades [12–18]. The ﬁbril
formation of amyloid beta (Ab), another amyloidogenic peptide
which is known to be associated with Alzheimer’s disease, has al-
ready been shown to be modulated by cholesterol [18–21]. Signif-
icant amounts of detergent-insoluble Ab were detected in lipid
rafts rich in gangliosides, sphingomyelin, and cholesterol [20].
Moreover, highly concentrated Ab was found in lipid rafts of the
brain in Tg2576 transgenic mice [21]. It is to be noted that IAPP
and Ab display an amino-acid similarity in their presumably or-
dered region, and a secondary structure similarity in their ﬁbrillar
states [22]. Raft lipids may in fact be a common component of hu-
man extracellular amyloid ﬁbrils [23]. Therefore, testing the inﬂu-
ence of raft-model systems on the ﬁbrillation of IAPP and possible
associated membrane-disrupting effects becomes of obvious inter-
est for biophysical investigations. The lipid mixture of our choice,
DOPC:DPPC:cholesterol 1:2:1, exhibits liquid-ordered (lo)/liquid-
disordered (ld) phase coexistence at room temperature, the lo phase
being cholesterol-rich. To the best of our knowledge, this is the ﬁrst
biophysical study to explore the interaction of IAPP with model raft
membranes.lsevier B.V. All rights reserved.
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study regarding the interaction of IAPP with pancreatic b-cells
in culture [24]. Although IAPP ﬁbril formation has been shown
to induce apoptosis in the pancreatic b-cell line RINm5F, the nat-
ure of the species associated with its cytotoxicity is still under de-
bate. It has been suggested that in particular early oligomeric
species rather than mature ﬁbrils are responsible for this effect
[25], and speculated that this is primarily due to the destruction
of the barrier properties of the cell membrane [24]. Reliable cell
models are of major importance for diabetes research. Therefore,
in this study we focused on a cell line which has only been re-
cently established in the group of Dr. Pierre Maechler, INS-1E
[26], as a more suitable b-cell model than the previously reported
RINm5F cell line, since INS-1E shows a higher resemblance with
native b-cells [26].
Moreover, from an application point of view, we would like to
bring additional proof regarding the recently reported potent
inhibitor resveratrol, not only in inhibiting IAPP ﬁbril formation,
but also in inhibiting the associated cytotoxic effects [27], by visu-
alizing the inhibition of IAPP ﬁbril formation in the presence of res-
veratrol in cell studies. Since this small molecule inhibitor is a
natural polyphenolic compound, present in grapes and red wine,
it may be the basis of a very promising drug, due to its non-toxicity
and biocompatibility. The fact that it has been previously reported
as a potent inhibitor of Ab ﬁbril formation and cytotoxicity [28,29]
brings additional support to this idea; such inhibitors might very
well prove effective in the future at a larger scale against amyloido-
genesis of other proteins as well.
In the present study, ﬂuorescence microscopy (confocal and
two-photon excitation) imaging was employed as a powerful tool
in exploring the IAPP-raft membrane interaction and the inhibitory
effect of resveratrol. By a proper choice of ﬂuorophores, it was pos-
sible to simultaneously monitor both the localization of membrane
lipids and that of the peptide, along with ﬁbrillar growth and asso-
ciated membrane-disrupting effects, both on membrane model
systems, such as giant unilamellar lipid vesicles (GUVs) of the
canonical raft-like mixture DOPC:DPPC:cholesterol 1:2:1, as well
as on the pancreatic INS-1E b-cells. Also, the importance of electro-
static vs. hydrophobic interactions in IAPP ﬁbril formation at the li-
pid interface is critically discussed, based on the present study and
previously reported literature data.2. Materials and methods
2.1. Materials
DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) and DPPC
(1,2-dipalmitoyl-sn-glycero-3-phosphocholine) were from Avanti
Polar Lipids (Alabaster, AL, USA). Cholesterol and resveratrol were
purchased from Sigma (Schnelldorf, Germany), and hexaﬂuoroiso-
propanol (HFIP) from Riedel de Haen (Seelze, Germany). The ﬂuo-
rescent lipids were purchased from Molecular Probes (Karlsruhe,
Germany). C-terminally amidated synthetic human IAPP was ob-
tained from Calbiochem (San Diego, USA), and the ﬂuorescently la-
beled synthetic human IAPP-K-Bodipy-FL from Peptide Specialty
(PSL) Laboratories (Heidelberg, Germany), respectively. The INS-
1E rat insulinoma b-cells were a gift from Dr. Pierre Maechler
(Department of Cell Physiology and Metabolism, University Medi-
cal Centre, Geneva, Switzerland). RPMI 1640 medium (with 2 mM
glutamine) was purchased from Gibco-Invitrogen (Karlsruhe, Ger-
many) and fetal calf serum from Brunschwig (Basel, Switzerland).
HEPES, 2-mercaptoethanol, sodium pyruvate, penicillin, strepto-
mycin and trypsine were bought from AppliChem (Darmstadt,
Germany). All other chemicals were of the highest purity grade
available.2.2. IAPP and resveratrol sample preparation
IAPP and IAPP-K-Bodipy-FL were individually and brieﬂy dis-
solved in HFIP to disaggregate the protein, followed by removal
of the solvent by lyophilization. The peptide was rehydrated at
the desired concentration with a suitable solvent, depending on
the intended measurement. Either IAPP or IAPP-L-Bodipy-FL was
added to the GUVs chamber at a ﬁnal 5 lM concentration, and to
INS-1E cells at 10 lM, respectively. A 10 mM stock of resveratrol
was prepared in DMSO and further sub-stocks were made from
this so that a ﬁnal 1% vehicle (DMSO) was present during ﬁbril for-
mation. In combination with resveratrol (resveratrol stocks in
DMSO), IAPP was used at a concentration of 10 lM and a 1:1 molar
ratio.
2.3. Vesicle preparation and lipid membrane ﬂuorescence labeling
GUVs were prepared by electroformation [30,31,15,16] in a
home-made chamber on Pt wires. Individual lipid stocks were pre-
pared at 10 mg/mL and mixed at a 1:2:1 molar ratio
(DOPC:DPPC:cholesterol), yielding 200 lL lipid mixture, into which
6 lL of a 1 mM rhodamine-DHPE chloroform stock was added. The
sample was further diluted with chloroform and 2 lL of the result-
ing 0.2 mg/mL lipid mixture were spread on each Pt wire; subse-
quently, chloroform was removed in a freeze-dryer at high
vacuum for 1 h. The chamber was sealed with a cover slip and
the lipids were hydrated with 1.5 mL water, pre-warmed at
65 C, and electroformation was carried out for 90 min under AC,
at 3 V and 10 Hz, at 65 C, a temperature at which the lipid mixture
is known to be in the liquid-disordered (ld), ﬂuid-like phase. After
completion of electroformation, the temperature was slowly re-
duced at a constant rate of 1 C/min up to room temperature
(25 C). After choosing a region of interest for imaging of the GUVs
(of 30 lm diameter grown on Pt wires), the peptide of interest
was added into the chamber and the lipid–peptide interaction
was investigated over time via ﬂuorescence microscopy.
2.4. INS-1E cells culture and labeling
The cells were cultured in RPMI 1640 medium (with 2 mM glu-
tamine) supplemented with 5% fetal calf serum, 10 mM HEPES, pH
7.4, 1 mM sodium pyruvate, 50 lM 2-mercaptoethanol, 100 units/
mL penicillin and 0.1 mg/mL streptomycin, at 37 C, 5% CO2, pH 7.4.
The cells were seeded into 96-well plates at 10000 cells/well,
grown for 24 h prior to exposure to the agent to be tested
(10 lM IAPP, a mixture of IAPP and resveratrol (1:1 molar ratio),
or 10 lM resveratrol, respectively), and then exposed for different
incubation times. After this step, the supernatant was replaced
with a 5 lM membrane lipid probe (Texas Red-DHPE, 1 mM stock
in DMSO) in serum-free medium for 20 min, and afterwards the
medium was replaced with PBS buffer, pH 7.4, containing
0.9 mM CaCl2, 0.5 mM MgCl2 and 5 mM glucose, prior to the ﬂuo-
rescence microscopy investigations.
We have also tried to use Congo Red and Thioﬂavine T (ThT)
staining of the ﬁbrils formed. However, we encountered that
ThT was found to be toxic to INS-1E cells in the concentration
range required for quantitative estimation of IAPP ﬁbril formation
(several lM). Also Congo Red showed pronounced non-speciﬁc
binding to the cellular membranes of INS-1E cells. Moreover,
we found a pronounced spectroscopic cross-talk between this
dye and the cellular membrane marker Bodipy-DHPE, which
was used in this approach in combination with Congo Red. As a
consequence, we have opted for a different approach, where we
simultaneously monitored two ﬂuorescent dyes, with Bodipy
being covalently coupled to the IAPP molecule, and Texas Red-
DHPE as cellular membrane label.
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Images were recorded by a confocal laser scanning micro-
scope (Biorad MRC 1024, extended for multiphoton excitation,
now Zeiss, Germany) coupled via a side-port to an inverted
microscope (Nikon, Eclipse TE-300 DV, inﬁnity corrected optics)
enabling ﬂuorescence excitation in the focal plane of an objec-
tive lens (Nikon Plan Fluor 40, NA 0.6, extra long working
distance 3.7 mm). Fluorescence in the green and red PMT-chan-
nels (emission bandpass ﬁlters 522 nm/FWHM 35 nm and
580 nm/FWHM 40 nm, respectively) were acquired either
sequentially by alternating the excitation with the 488 and
568 nm lines of a Kr–Ar-Laser, or simultaneously by utilizing a
Ti-Sap-Laser (Coherent, Mira 900-F, 76 MHz repetition rate, ca.
250 fs pulse width, pumped by a 5 W Verdi) tuned to 820 nm
for optimal two-photon excitation of rhodamine-DHPE. Image
acquisition was controlled by the software LaserSharp2000 (for-
merly Biorad, now Zeiss).Fig. 1. Temperature scan for giant unilamellar lipid vesicles made from DOPC:DPPC:cho
transition from the l0/ld-coexistence region to the ld phase occurs at 40 C. Rhodam
(displayed in grey). The vesicle size is 30 lm.
Fig. 2. Interaction of islet amyloid polypeptide with raft-like GUVs (DOPC:DPPC:chole
Bodipy-FL, displayed in green) inserts preferentially into the ld lipid phase (displayed in g
strongest effects are observable within the ﬁrst hour of interaction. With time, IAPP ﬁ
reﬂecting the shape and size of the GUVs which serve as template here (30 lm diame3. Results and discussion
3.1. Interaction of IAPP with model raft GUVs prepared from
DOPC:DPPC:cholesterol 1:2:1
The lipid mixture DOPC:DPPC:cholesterol 1:2:1 displays liquid-
ordered (lo)/liquid-disordered (ld) phase coexistence at room tem-
perature. By gradually increasing the temperature, the transition to
the all-ﬂuid ld phase was detected to take place at 40 C (Fig. 1).
For visualization, we used the membrane ﬂuorescence marker rho-
damine-DHPE which is known to preferentially label the ld phase
(displayed in grey in Fig. 1), rather than the lo phase (displayed
in black). Above 40 C, the ﬂuorophore was found to be homoge-
nously distributed all over the membrane surface of the GUVs,
indicating the presence of a homogenous ld phase. Below that tem-
perature, phase separation can be clearly seen.
Since we are essentially interested in the lipid phase coexis-
tence region here, and how it can modulate peptide insertionlesterol 1:2:1. The GUVs display l0/ld phase coexistence at room temperature. The
ine-DHPE was used as membrane marker, labeling preferentially the ld domains
sterol 1:2:1) monitored at room temperature. C-terminally labeled IAPP (IAPP-K-
rey), the insertion being already detectable 2 min after peptide addition (5 lM). The
brils grow at the expense of membrane material, adopting a circular shape, thus
ter). The scale bar represents 10 lm.
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the system at room temperature, i.e., at 25 C (Fig. 2). Prior to pep-
tide insertion into the membrane, no signiﬁcant cross-talk be-
tween the red (rhodamine-DHPE) and the green (Bodipy-FL)
channel was detected (Fig. 2 0 min). Within 1–2 min after peptide
addition, insertion of the C-terminally Bodipy-FL-labeled IAPP
(IAPP(1-37)-K-Bodipy-FL) into the GUVs membranes is already de-
tected. Moreover, the peptide seems to preferentially partition into
the ld phase, already strongly affecting the lipid bilayer integrity
within minutes after its addition.
Our time-lapse study indicates drastic changes in the GUVs
morphology due to the strong interaction with IAPP, especially
within the ﬁrst hour of interaction (readings at 2, 35 and 60 min,
after exposing the membrane to the peptide). With time, IAPP in-
duces detachment of the otherwise stable GUVs from the platinumFig. 3. Interaction of IAPP with INS-1E cells at different time points monitored by ﬂuores
of IAPP, lipids getting incorporated into the growing IAPP ﬁbrils (25–50 lm length, 1.5–4
anymore. Non-treated cells were used as control (data not shown). Green: IAPP-K-Bodip
channels showing co-localization of IAPP and cell membranes. The scale bar correspondwires and incorporation of membrane lipids into the growing ﬁ-
brils. Therefore, bent structures (after 1 h) and circularly-shaped
ﬁbrils (after 72 h) grow on the surface of available GUV tem-
plates. After 72 h of incubation, a perfect overlap of the ﬂuores-
cent signals in the two detection channels is seen, and no intact
GUVs are detectable at this point anymore. These ﬁndings indicate
an overall pronounced association/incorporation of lipids into the
growing IAPP ﬁbrils.
For comparison, we have also investigated the interaction of
the same lipid system with unlabeled IAPP (data not shown).
Identically prepared GUVs were in this case treated with 5 lM
IAPP instead of 5 lM IAPP-K-Bodipy-FL. Under these conditions,
we did not detect any inﬂuence of the ﬂuorescence label on
the interaction with the lipid membrane, and thus, on the mech-
anism and kinetics of IAPP aggregation. A similar kinetics ofcence microscopy. The barrier function of cellular membranes is lost in the presence
lm thickness). After 24 h, no signiﬁcant increase in ﬁbril dimensions was observed
y-FL, red: Texas-Red DHPE labeled INS-1E cells, yellow: merge of the two detection
s to 10 lm.
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was observed, with the most drastic changes occurring within
the ﬁrst hour after addition of the peptide. This ﬁnding is also
in agreement with supplementary atomic force microscopy
(AFM) measurements showing disruption of the raft membrane
at an early stage of the ﬁbrillation reaction of IAPP (data not
shown).
Several studies reported in the literature had previously indi-
cated that the positively charged N-terminus is responsible for
the insertion of IAPP into negatively lipid monolayers mainly via
electrostatic interactions [10], and this is also the reason why we
opted for the C-terminal labeling of IAPP (PSL Laboratories, Heidel-
berg). However, understanding IAPP-membrane interactions
seems to be more complex, and electrostatic interactions are prob-
ably not the only important type of interaction present [11]. It is to
be noted that the even more positively charged rodent IAPP does
not seem to insert strongly into negatively charged membranes
(H18 in human IAPP corresponds to R18 in rodent IAPP) [21] and
that the negatively charged DNA has a less pronounced accelerat-
ing effect on IAPP ﬁbril formation as compared to anionic lipids [4],
thus strengthening the important role of the hydrophobic lipid
core region in IAPP ﬁbril formation. Recently, it has been suggested
that the interaction of IAPP with lipid head-groups via charge
interaction might essentially lower the energy barrier for separat-
ing neighboring lipid molecules and inserting between the lipid
chains [32]. The previously reported literature data, and the strong
peptide-membrane interaction observed in our study on the zwit-
terionic raft-model system, involving membrane damage, associ-
ated ﬁbril growth and lipid incorporation into the growing ﬁbrils,
clearly demonstrate that the nature of the interaction is not purely
electrostatic, but rather that, once adsorbed and partially inserted,
IAPP will interact with the membrane via hydrophobic interac-
tions, thus facilitating further peptide penetration, which leads to
an increase in local peptide concentration in the membrane’s core
region. Once hydrophobic patches of membrane lipid chains are
exposed to IAPP, the peptide will probably start ‘‘pulling” mem-
brane lipids into the growing ﬁbrils. In fact, hydrophobic interac-
tions are also considered to be a major driving force in IAPP ﬁbril
formation in the absence of membranes [33]. These ﬁndings may
as well be the starting point of further studies on amyloidogenicFig. 4. Inhibition of IAPP ﬁbril formation and reduced cytotoxicity in the presence of res
IAPP and resveratrol at a 1:1 molar ratio. Both for the 24 and 48 h-treated samples, no ﬁb
cytotoxicity acquired by efﬁcient inhibition of IAPP aggregation by resveratrol at an early
pathway oligomers, are detected both in the vicinity of the cell membrane as well as in th
merge of the two detection channels, showing the localization of IAPP non-toxic oligomer
corresponds to 10 lm.peptides regarding the modulation of ﬁbril formation by lipid
in vivo.
3.2. Interaction of IAPP with INS-1E cells and inhibition of IAPP ﬁbril
formation and associated cytotoxicity by resveratrol
We have recently reported the potential use of resveratrol in
preventing IAPP ﬁbril formation both in the absence and presence
of membranes, as well as in the b-cellular model INS-1E [27]. By
using a WST-1 cell proliferation assay, we demonstrated the inhi-
bition of IAPP cytotoxicity by resveratrol on INS-1E cells (Fig. 4,
[27]). Here, we are visualizing the interaction of IAPP with INS-
1E cells (Fig. 3), and additionally reveal the IAPP species formed
in the presence of this potent inhibitor, with the aid of ﬂuorescence
microscopy imaging. IAPP readily inserts into the cell membrane
within the ﬁrst minutes of interaction (readings at 10, 20,
30 min, 1 h, data not shown), and ﬁbrils grow at the expense of cel-
lular membranes.
After 3 h, ﬁbrils already incorporated lipid membrane material,
leading to structures of about 10 lm length and 2 lm thickness
(Fig. 3 3 h).
As the barrier function of the cellular membranes is lost, lipids
and cellular material gets incorporated into the growing ﬁbrils,
thus explaining the unusual thickness and length of the ﬁbrils
(i.e., 25–50 lm length, 1.5–4 lm thickness) compared to the corre-
sponding dimensions in the in vitro studies [27,33,34]. A branching
and twisting tendency was also observed. In all investigated sam-
ples, cellular lipids were incorporated into the ﬁbrils, and after 24 h
no signiﬁcant increase in ﬁbril dimensions was observed anymore.
By using non-treated cells as well, it was obvious that the observed
cellular morphological changes can be attributed to IAPP-induced
cell death, in line with our previously reported results using the
WST-1 assay [27].
Extending the discussion from Section 3.1 regarding the inter-
action of IAPP with lipid membranes, it is quite obvious that in
the case of cellular studies, the situation may be much more com-
plex. It is not only the lipid membranes that create a hydrophobic
environment, thus allowing IAPP to penetrate into the lipid bilayer.
Additional factors might also play an important role in attracting
IAPP to the cellular surface, thus facilitating its aggregation. Forveratrol on INS-1E cells at different time points. Cells were exposed to mixtures of
rillar structures are observed. The intact cell morphologies account for the reduced
stage. Small spherical oligomeric particles (1.5 lm diameter), possibly non-toxic off-
e bulk. Green: IAPP-K-Bodipy-FL, red: Texas-Red DHPE labeled INS-1E cells, yellow:
ic aggregates, both near INS-1 E cell membranes as well as in the bulk. The scale bar
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glycans might additionally contribute to amyloid formation [35].
It is clearly seen that resveratrol arrests IAPP ﬁbril formation
and associated cytotoxic effects at an early stage (Fig. 4). Since it
is generally believed that early oligomers may be more cytotoxic
than mature ﬁbrils, it can be speculated that in this case resveratrol
leads to formation of non-toxic, off-pathway amorphous aggre-
gates of approximately 1.5 lm diameter. Insertion into the mem-
brane is largely prevented, since such structures are also visible
in the bulk as illustrated in Fig. 4, both for the 24 h-, as well as
for the 48 h-treated sample. Our ﬂuorescence microscopy results,
taken together with the WST-1 assay outcome [27], clearly show
that the changes in morphology observed for cells treated with
IAPP-resveratrol mixtures, compared to IAPP-treated cells, corre-
late with the change in toxicity.4. Concluding remarks
The interaction studies with the model-raft lipid system have
shown that IAPP partitions preferentially into the liquid-disor-
dered (ld) lipid phase within minutes after addition of the pep-
tide, which is followed by subsequent membrane disintegration.
Under such experimental conditions (5 lM IAPP, 25 C), ﬁbrilla-
tion of IAPP does not take place in the bulk solvent in this time
range. To diminish energetic costs, incorporation of the peptides
at the rim of the domains would be most favorable, leading to
a favorable decrease of the associated line tension, which then
spread over the whole ﬂuid domain region. Insertion into the li-
quid-ordered raft domains can be clearly ruled out. Predomi-
nantly circularly-shaped IAPP amyloid constructs are formed on
the GUV templates, incorporating membrane lipids. The amy-
loid-lipid aggregates reach sizes of about 30 lm in diameter.
Hence, this study clearly demonstrates the important ability of
heterogeneous membranes in IAPP amyloid formation in vitro
and in vivo. Interestingly, membrane incorporation into IAPP ﬁ-
brils was also observed in our cellular studies on INS-1E cells,
ﬁbrillar structures being typically 25–50 lm long and 1.5–4 lm
thick. Our conclusions on model-raft systems and INS-1E cells
are very well complemented by studies of Sparr et al. [24], who
used different (non-raft) model lipid systems and a different cell
line, and also observed lipid uptake into amyloid ﬁbers, ruling out
formation of discrete protein pores [5]. All these results clearly
point towards the incorporation of lipid upon IAPP ﬁbril forma-
tion, with hydrophobic interactions being a major player in mem-
brane-associated amyloid formation and thus possibly in the
onset of T2DM, once the barrier function of the cell membrane
is lost. It may very well be that lipid-containing amyloid aggre-
gates are universal structures of amyloid in living cells.
The imaging studies additionally indicate that the pronounced
cytotoxicity of IAPP on INS-1E cells can be largely overcome by
inhibition of IAPP ﬁbrillation by the red wine compound resvera-
trol, which is able to arrest IAPP ﬁbril formation at an early stage,
possibly leading to the formation of non-toxic, ‘‘off-pathway” large
oligomeric and amorphous structures. Since resveratrol is non-
toxic to pancreatic b-cells, this natural polyphenol might have
the potential to be developed as drug candidate against type II dia-
betes, and presumably towards other amyloidogenic diseases as
well in the future.Acknowledgements
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